Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Daratumumab in transplant regimens for myeloma?
Harousseau JL, Mohty M. Harousseau JL, et al. Blood. 2020 Aug 20;136(8):917-918. doi: 10.1182/blood.2020006298. Blood. 2020. PMID: 32818244 Free article. No abstract available.
Relapsed refractory multiple myeloma: a comprehensive overview.
Bazarbachi AH, Al Hamed R, Malard F, Harousseau JL, Mohty M. Bazarbachi AH, et al. Among authors: harousseau jl. Leukemia. 2019 Oct;33(10):2343-2357. doi: 10.1038/s41375-019-0561-2. Epub 2019 Aug 27. Leukemia. 2019. PMID: 31455853 Review.
Comprehensive Review of AL amyloidosis: some practical recommendations.
Al Hamed R, Bazarbachi AH, Bazarbachi A, Malard F, Harousseau JL, Mohty M. Al Hamed R, et al. Among authors: harousseau jl. Blood Cancer J. 2021 May 18;11(5):97. doi: 10.1038/s41408-021-00486-4. Blood Cancer J. 2021. PMID: 34006856 Free PMC article. Review.
Up-front ixazomib in older patients with myeloma.
Harousseau JL, Mohty M. Harousseau JL, et al. Blood. 2021 Jul 1;137(26):3584-3586. doi: 10.1182/blood.2021011262. Blood. 2021. PMID: 34196682 Free article. No abstract available.
Requirements for operational cure in multiple myeloma.
Mohty M, Avet-Loiseau H, Harousseau JL. Mohty M, et al. Among authors: harousseau jl. Blood. 2021 Oct 21;138(16):1406-1411. doi: 10.1182/blood.2021012854. Blood. 2021. PMID: 34324647 Free article.
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.
Harousseau JL, Attal M, Avet-Loiseau H, Marit G, Caillot D, Mohty M, Lenain P, Hulin C, Facon T, Casassus P, Michallet M, Maisonneuve H, Benboubker L, Maloisel F, Petillon MO, Webb I, Mathiot C, Moreau P. Harousseau JL, et al. J Clin Oncol. 2010 Oct 20;28(30):4621-9. doi: 10.1200/JCO.2009.27.9158. Epub 2010 Sep 7. J Clin Oncol. 2010. PMID: 20823406 Clinical Trial.
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
Avet-Loiseau H, Malard F, Campion L, Magrangeas F, Sebban C, Lioure B, Decaux O, Lamy T, Legros L, Fuzibet JG, Michallet M, Corront B, Lenain P, Hulin C, Mathiot C, Attal M, Facon T, Harousseau JL, Minvielle S, Moreau P; Intergroupe Francophone du Myélome. Avet-Loiseau H, et al. Among authors: harousseau jl. Blood. 2011 Feb 10;117(6):2009-11. doi: 10.1182/blood-2010-07-295105. Epub 2010 Oct 20. Blood. 2011. PMID: 20962323 Free article. Clinical Trial.
550 results